Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma

NCT05260619 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Lymphoma

Interventions

DRUG: lenalidomide

Sponsor

Seoul National University Bundang Hospital

Collaborators

[object Object]